Global Microbial Identification Market Report 2024

The microbial identification market size has grown rapidly in recent years. It will grow from $4.82 billion in 2023 to $5.57 billion in 2024 at a compound annual growth rate (CAGR) of 15.4%. The historical growth can be attributed to several factors, including government initiatives and funding aimed at promoting microbial identification, increasing FDA approvals, and growing health awareness among the population.

The microbial identification market size is expected to see rapid growth in the next few years. It will grow to $9.92 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The anticipated growth in the forecast period can be attributed to growing concerns about food safety, the rising incidence of infectious diseases, and an increasing frequency of pandemics. Major trends expected in the forecast period encompass technological advancements in microbial identification methods, continuous advancements in automation, molecular diagnostics, genomics, and the formation of strategic partnerships within the industry.

The increasing incidence of infectious diseases is poised to drive the growth of the microbial identification market in the foreseeable future. Infectious diseases are caused by various pathogenic microorganisms such as bacteria, viruses, fungi, parasites, or prions. Factors contributing to the occurrence of infectious diseases include climate change, environmental disruption, antimicrobial resistance, weakened immune systems, and ecological disturbances. Microbial identification plays a crucial role in accurately diagnosing infectious diseases, enabling targeted treatment, disease surveillance, outbreak control, and antimicrobial stewardship. For example, as reported by gov.uk, in England, there were 3,805 new HIV diagnoses in 2022, representing a 22% increase from the 3,118 cases reported in 2021 and a 26% rise from the 3,026 cases reported in 2020. Therefore, the rising prevalence of infectious diseases is fueling the demand for microbial identification solutions.

Key players in the microbial identification market are focusing on developing mass spectrum technology to improve the accuracy and speed of microorganism identification, which is essential for various applications such as clinical diagnostics, environmental monitoring, and food safety. Mass spectrum technology enables rapid and reliable identification of microorganisms down to the species level within minutes, offering a cost-effective and efficient alternative to traditional biochemical assays and sequencing methods. For instance, in January 2021, Bruker, a US-based manufacturer of microbial identification solutions, introduced an MS-based rapid microbial identification kit designed to meet the latest industry requirements. This kit represents a significant advancement in microbial identification, leveraging MALDI-TOF MS technology, which has become the standard in clinical microbiology laboratories. It provides faster, more efficient, and cost-effective analysis compared to conventional biochemical assays or sequencing methods.

In January 2021, Bruker, a US-based technology company, completed the acquisition of MERLIN Inc. for an undisclosed amount. The acquisition aimed to capitalize on MERLIN's expertise in antibiotic resistance and susceptibility testing (AST) to enhance Bruker's offerings in this area, aligning with Bruker's commitment to delivering high-value scientific instruments and innovative solutions. MERLIN, based in the UK, is known for manufacturing various products for microbial identification.

Major companies operating in the microbial identification market are Merck & Co. Inc., Sanofi S A, ThermoFisher Scientific Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, Avantor Inc., Eurofins Scientific Corporation, Beckman Coulter Inc., VWR International LLC, Charles River Laboratories International Inc., Perkinelmer Inc., Wickham Micro Limited, Bruker Corporation, BioMerieux S.A., Biolog Inc., Liofilchem S.r.l, BioMérieux SA, Shimadzu Corporation, Scenker Biological Technology Co. Ltd.

North America was the largest region in the microbial identification market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbial identification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the microbial identification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Microbial identification involves determining and categorizing microorganisms such as bacteria, fungi, viruses, and protozoa based on their phenotypic and genotypic traits. The integration of these methods enables accurate, rapid, and comprehensive identification, critical for diagnosing, treating, and monitoring infections.

The primary product types and services for microbial identification include instruments, consumables, and services. Microbial identification instruments are devices used to detect, classify, and identify microorganisms across various applications such as diagnostic, environmental, food and beverage testing, and pharmaceutical sectors. Methods employed encompass phenotypic, proteotypic, and genotypic approaches. These solutions are utilized by diverse end users including the pharmaceutical and biotechnology industry, food and beverage industry, water and environmental industry, independent research laboratories, diagnostic laboratories, hospitals, and others.

The microbial identification market research report is one of a series of new reports that provides microbial identification market statistics, including microbial identification industry global market size, regional shares, competitors with a microbial identification market share, detailed microbial identification market segments, market trends and opportunities, and any further data you may need to thrive in the microbial identification industry. This microbial identification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The microbial identification market consists of revenues earned by entities by providing services such as custom and specialized testing, clinical diagnostics, and microbial source tracking. Only goods and services traded between entities or sold to end consumers are included. The microbial identification market also consists of sales of microarray systems, genomic instruments, and culture testing instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.